Results 31 to 40 of about 82,196 (246)

Buprenorphine for Opioid Use Disorder in the Emergency Department: A Retrospective Chart Review

Western Journal of Emergency Medicine, 2020
Introduction: Emergency care providers routinely treat patients with acute presentations and sequelae of opioid use disorder. An emergency physician and pharmacist implemented a protocol using buprenorphine for the treatment of patients with opioid ...
Kathy T. LeSaint, Brent Klapthor, Ralph C. Wang, Curtis Geier   +3 more
doaj   +1 more source

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018

Addiction Science & Clinical Practice, 2022
Background Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis.
Kevin P. Conway, Dalia Khoury, Rainer Hilscher, Arnie P. Aldridge, Stephanie J. Parker, Gary A. Zarkin   +5 more
doaj   +1 more source

Emergency Department Clinicians’ Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study [PDF]

, 2020
Introduction: Emergency department (ED) visits related to opioid use disorder (OUD) have increased nearly twofold over the last decade. Treatment with buprenorphine has been demonstrated to decrease opioid-related overdose deaths. In this study, we aimed
Carlson, Lucas C., Chary, Anita, Condella, Anna L., Im, Dana D., Kunzler, Nathan, Martin, Alister, Samuels-Kalow, Margaret, Vogel, Lara, Vongsachang, Hurnan, Weiner, Scott G.   +9 more
core  

Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions

Western Journal of Emergency Medicine, 2022
Emergency departments (ED) are increasingly providing buprenorphine to persons with opioid use disorder. Buprenorphine programs in the ED have strong support from public health leaders and emergency medicine specialty societies and have proven to be ...
Timothy D. Kelly, Kathryn F. Hawk, Elizabeth A. Samuels, Reuben J. Strayer, Jason A. Hoppe   +4 more
doaj   +1 more source

Perioperative Buprenorphine Management and Postoperative Pain Outcomes: A Retrospective Study with Evidence-Based Recommendations

International Journal of Translational Medicine
The prevalence of patients on buprenorphine therapy presenting for elective surgery has increased. Buprenorphine is a widely used medication for the management of patients with chronic pain.
Amruta Desai, Shruti Parikh, Sergio Bergese   +2 more
doaj   +1 more source

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach

Addiction Science & Clinical Practice, 2020
Background The requirement for moderate withdrawal prior to initiation can be a barrier to buprenorphine/naloxone induction. Case presentation We aimed to use a microdosing regimen to initiate regular dosing of buprenorphine/naloxone in a high-risk ...
Jennifer Rozylo, Keren Mitchell, Mohammadali Nikoo, S. Elise Durante, Skye P. Barbic, Daniel Lin, Steve Mathias, Pouya Azar   +7 more
doaj   +1 more source

Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats [PDF]

, 2017
The aim of this study was to describe the joint pharmacokinetic-pharmacodynamic model and evaluate thermal antinociception of a high-concentration formulation of buprenorphine (Simbadol™) in ...
A Yassen, AR Hedges, AR Hedges, Beatriz P. Monteiro, C Kilkenny, Daniel Edge, F Gaudreault, Francesco Staffieri, Francis Beaudry, Graeme M. Doodnaught, H Zhou, JA Johnson, Javier Benito, JW Gabrielsson, KM Messenger, L Pelligand, LB Sheiner, LS Slingsby, LS Slingsby, LS Slingsby, Ludovic Pelligand, MJ Dixon, MW Sadiq, Paulo Steagall, PL Toutain, PM Taylor, PM Taylor, PV Steagall, PVM Steagall, PVM Steagall, PVM Steagall, PVM Steagall, RL Niedfeldt, SA Robertson, SA Robertson, SL Ellis   +35 more
core   +3 more sources

Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder - a case report

European Psychiatry
Introduction Opioid dependence is a complex condition that often requires long-term treatment and care. Methadone, a synthetic full opioid agonist, and buprenorphine, a partial agonist at the opioid receptor, are most commonly used for substitution ...
M. Delic
doaj   +1 more source

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018

Drug and Alcohol Dependence Reports, 2023
Background: Although use of buprenorphine for treating opioid use disorder increased over the past decade, buprenorphine utilization remains limited in lower-income and rural areas.
Olivia K. Golan, Flora Sheng, Andrew W. Dick, Mark Sorbero, Daniel J. Whitaker, Barbara Andraka-Christou, Therese Pigott, Adam J. Gordon, Bradley D. Stein   +8 more
doaj  

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study

Annals of Medicine, 2023
Background: At the start of the pandemic, relaxation of buprenorphine prescribing regulations created an opportunity to create new models of medications for opioid use disorder (MOUD) delivery and care.
Edward Suarez, Tyler S. Bartholomew, Marina Plesons, Katrina Ciraldo, Lily Ostrer, David P. Serota, Teresa A. Chueng, Morgan Frederick, Jason Onugha, Hansel E. Tookes   +9 more
doaj   +1 more source